Defective Hip Replacements: Biomet Agrees to Settlements

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Indiana-based Biomet, Inc. has agreed to settle hundreds of lawsuits over its defective hip replacements, the M2A Magnum. The law suits claim that the hip implants needed to be replaced due to the defect. 

In a statement released last month, a company spokesperson stated “Biomet is pleased to have reached this settlement and have the MDL (multi-state litigation) resolved.”

In documents filed with the Securities and Exchange Commission, the company indicated that the total payout could ultimately exceed $50 million. Claimants who had a Biomet M2A Magnum hip replaced are slated to receive a “base” settlement of $200,000 each. Higher individual amounts can be paid on a case-by-case basis.

In November 2013, Johnson & Johnson, which manufactures DePuy hip implants, announced that it would pay $2.5 billion to settle an estimated 8,000 lawsuits arising out of its metal-on-metal implants. DePuy implants were pulled from the market in 2010 after studies revealed premature failures of those implants.

Stryker, Inc, manufacturer of the M2A Magnum metal-on-metal hip implants, also announced settlement of four lawsuits involving its defective hip replacements. Details and amounts of the settlements were not revealed.

Clark, Perdue & List, Ohio hip implant attorneys, have represented many individuals who have been injured by metal-on-metal hip implants, as well as other defective medical devices and dangerous drugs. If you or a loved one has suffered injury as a result of a defective or dangerous medical product, call Clark, Perdue & List.